home / stock / tear / tear quote
Last: | $0.0579 |
---|---|
Change Percent: | 1.49% |
Open: | $0.05705 |
Close: | $0.0579 |
High: | $0.0579 |
Low: | $0.0571 |
Volume: | 20,250 |
Last Trade Date Time: | 07/09/2020 04:55:16 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0579 | $0.05705 | $0.0579 | $0.0579 | $0.0571 | 20,250 | 07-09-2020 |
$0.059 | $0.0561 | $0.059 | $0.059 | $0.0561 | 44,921 | 07-07-2020 |
$0.0571 | $0.0562 | $0.0571 | $0.0571 | $0.0561 | 54,370 | 07-06-2020 |
$0.0563 | $0.056825 | $0.0563 | $0.0578 | $0.0563 | 57,170 | 07-03-2020 |
$0.0563 | $0.056825 | $0.0563 | $0.0578 | $0.0563 | 57,170 | 07-02-2020 |
$0.0563 | $0.0563 | $0.0563 | $0.0563 | $0.0563 | 1,162 | 07-01-2020 |
$0.0562 | $0.05735 | $0.0562 | $0.0574 | $0.0562 | 46,200 | 06-30-2020 |
$0.0569 | $0.0569 | $0.0569 | $0.0569 | $0.0569 | 3,221 | 06-29-2020 |
$0.0565 | $0.0561 | $0.0565 | $0.0578 | $0.0561 | 118,823 | 06-26-2020 |
$0.0561 | $0.0561 | $0.0561 | $0.057 | $0.0561 | 22,971 | 06-25-2020 |
$0.057 | $0.0561 | $0.057 | $0.057 | $0.0561 | 31,535 | 06-24-2020 |
$0.0569 | $0.0579 | $0.0569 | $0.0579 | $0.0569 | 17,259 | 06-23-2020 |
$0.0579 | $0.0567 | $0.0579 | $0.0579 | $0.0555 | 82,825 | 06-22-2020 |
$0.0567 | $0.0567 | $0.0567 | $0.0567 | $0.0567 | 150 | 06-19-2020 |
$0.057 | $0.0548 | $0.057 | $0.0578 | $0.0548 | 121,865 | 06-18-2020 |
$0.0547 | $0.0546 | $0.0547 | $0.0547 | $0.0546 | 14,585 | 06-17-2020 |
$0.0552 | $0.05425 | $0.0552 | $0.0561 | $0.0543 | 121,090 | 06-15-2020 |
$0.0552 | $0.0552 | $0.0552 | $0.0552 | $0.0552 | 406 | 06-11-2020 |
$0.0552 | $0.0569 | $0.0552 | $0.0569 | $0.0552 | 1,312 | 06-10-2020 |
$0.0552 | $0.05605 | $0.0552 | $0.0569 | $0.0552 | 23,789 | 06-09-2020 |
News, Short Squeeze, Breakout and More Instantly...
TearLab Corp - Ordinary Shares Company Name:
TEAR Stock Symbol:
OTCMKTS Market:
ESCONDIDO, Calif. , May 11, 2020 /PRNewswire/ -- TearLab Corporation (OTCQB: TEAR), a leader in Ocular Surface Diagnostics, today announced it has entered into a definitive agreement pursuant to which Accelmed Partners II (AP-II) will acquire TearLab. In connection with the acquisiti...
ESCONDIDO, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- In light of recent market rumors, TearLab Corporation (OTCQB: TEAR) (“TearLab”) today confirmed that TearLab is engaged in advanced discussions regarding a potential business combination whereby TearLab will be acquired at a ...
ESCONDIDO, Calif., April 22, 2020 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB: TEAR) (“TearLab” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has accepted the resubmission of its 510(k) application for the potential clearan...